Suppressive effects of the expectorant drug ambroxol hydrochloride on quartz-induced lung inflammation in F344 rats-Reference-Cited by-同舟云学术

Suppressive effects of the expectorant drug ambroxol hydrochloride on quartz-induced lung inflammation in F344 rats

Published:2017 Issue:2 Volume:30 Page:153-159
ISSN:0914-9198
Container-title:Journal of Toxicologic Pathology
language:en
Short-container-title:J Toxicol Pathol

Author:

Kanie Shohei¹²,Yokohira Masanao¹,Yamakawa Keiko¹,Nakano-Narusawa Yuko¹,Yoshida Shota¹²,Hashimoto Nozomi¹,Imaida Katsumi¹

Affiliation:

1. Onco-Pathology, Department of Pathology and Host Defense, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793, Japan

2. Toxicology Laboratory, Discovery and Preclinical Research Division, TAIHO Pharmaceutical Co., Ltd., 224-2 Ebisuno, Hiraishi, Kawauchi-cho, Tokushima 771-0194, Japan

Publisher

Japanese Society of Toxicologic Pathology

Subject

Toxicology,Pathology and Forensic Medicine

Link

https://www.jstage.jst.go.jp/article/tox/30/2/30_2016-0050/_pdf

Reference27 articles.

1. 1. Pérez-Gil J, and Keough KMW. Interfacial properties of surfactant proteins. Biochim Biophys Acta. 1408: 203–217. 1998.

2. 2. Yokohira M, Yamakawa K, Nakano Y, Numano T, Furukawa F, Kishi S, Ninomiya F, Kanie S, Hitotsumachi H, Saoo K, and Imaida K. Immunohistochemical characteristics of surfactant proteins A, B, C and D in inflammatory and tumorigenic lung lesions of F344 rats. J Toxicol Pathol. 27: 175–182. 2014.

3. 3. Perez-Gil J, and Weaver TE. Pulmonary surfactant pathophysiology: current models and open questions. Physiology (Bethesda). 25: 132–141. 2010.

4. 4. Houtmeyers E, Gosselink R, Gayan-Ramirez G, and Decramer M. Effects of drugs on mucus clearance. Eur Respir J. 14: 452–467. 1999.

5. 5. Nagahama F, Ito N, Momose T, Ogiwara M, Suetsugu S, Umeda H, Kawai M, Maekawa N, Inaba N, Oda Y, Uchihira F, Konishiike J, Sera Y, Ooka Y, Oishi M, Nakajima S, Sewake N, Mochizuki K, Kodomari N, Inoue K, Tsurutani H, and Nagano H. Efficacy and safety of long-term treatment with mucolytic agent (NA872) in chronic respiratory disease patients. Yakuri To Chiryo. 9: 2091–2104. 1981. (in Japanese)

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between Lung Carcinogenesis and Chronic Inflammation in Rodents;Cancers;2021-06-10

2. Co-aerosolized Pulmonary Surfactant and Ambroxol for COVID-19 ARDS Intervention: What Are We Waiting for?;Frontiers in Bioengineering and Biotechnology;2020-09-25

3. Value of ambroxol in the treatment of asthmatic bronchitis;Pakistan Journal of Medical Sciences;2020-03-04

4. Protective effects of ambroxol in psoriasis like skin inflammation: Exploration of possible mechanisms;International Immunopharmacology;2019-06

5. Effects of the expectorant drug ambroxol hydrochloride on chemically induced lung inflammatory and neoplastic lesions in rodents;Journal of Toxicologic Pathology;2018